Not an accurate indicator of success, to be sure, but it's better than seeing insiders bailing.
Many sub 1$ health/biotech/device companies hit rock bottom earlier this year and have amazingly rocketed to prices unimaginable in March. They have much bigger debt loads than CTGI and products with a much more limited scope.
They also have excitement, usually in the form of an FDA application about to be decided, a JV on the front burner or encouraging results from an early phase trial. The sector has been white hot. Check out the 3 month and the 5 day on NEPH, for example.
Unfortunately, CTGI currently generates the excitement of a stale cheese fart. We can only hope that there's some substantial negotiations quietly occurring, and that our poster boys, Frank and Richard, are leading the proceedings. They have the experience and the connections in the industry, and signing them up is one thing DR should get credit for.
If they're still ACTIVE with CTGI, we have a shot. If they've sold their positions and moved on.......well, let's hope that isn't the case....lol.
